中国平安（601318）(601318.SH)披露2025年中期报告，集团实现营业收入5000.76亿元，同比增长1.0%; 归属于母公司股东的营运利润777.32亿元，同比增长3.7%;归属于母公司股东的净利润680.47亿元。将向 股东派发中期股息每股现金人民币0.95元。 2025年上半年，寿险及健康险业务新业务价值达成223.35亿元，同比大增39.8%。业务品质稳步改善。 平安寿险保单继续率保持较高水平，13个月保单继续率达96.9%，同比上升0.3个百分点;25个月保单继 续率95.0%，同比上升4.1个百分点。多渠道能力全面发展，2025年上半年，代理人渠道新业务价值同比 增长17.0%，代理人人均新业务价值同比增长21.6%。银保渠道新业务价值59.72亿元，同比增长 168.6%。银保渠道、社区金融服务及其他等渠道，贡献了平安寿险新业务价值的33.9%。供给高质 量"保险产品+服务"，2025年上半年，已有超1300万平安寿险的客户使用健康管理服务。 2025年上半年，平安产险实现原保险保费收入1718.57亿元，同比增长7.1%;保险服务收入1656.61亿元， 同比增长2.3%;整体综合 ...

Core Insights - Sunac China (01918) reported a mid-year performance for 2025, with revenue approximately RMB 19.99 billion, a decrease of about 41.7% compared to the same period last year [1] - The company experienced a gross loss of approximately RMB 2.08 billion, an increase of about 14.9% year-on-year [1] - Loss attributable to shareholders was approximately RMB 12.81 billion, a decrease of about 14.4% compared to the same period last year, with a loss per share of RMB 1.26 [1] Revenue and Sales Performance - The decline in revenue was primarily due to a decrease in property sales revenue, which fell by approximately 50.1% to RMB 14 billion [1] - The total area of property deliveries decreased by approximately 39.1% to 1.695 million square meters [1] Land Reserves - As of June 30, 2025, the group, including its joint ventures and associates, had total land reserves of approximately 124 million square meters (equity land reserves of approximately 86.24 million square meters) [1] - Among these, unsold land reserves were approximately 92 million square meters (equity land reserves of approximately 63.06 million square meters), indicating a solid foundation for the group to gradually restore normal operations in the future [1]

元续科技(08637)发布截至2025年6月30日止6个月中期业绩，集团收益2476.6万坡元，同比增长33.16%; 净利润313.2万坡元，同比增长49.36%;每股盈利2.1新加坡仙。 ...

Core Viewpoint - China General Nuclear Power Corporation (CGN) Mining reported a significant decline in its interim results for the six months ending June 30, 2025, with a revenue of HKD 1.709 billion, representing a year-on-year decrease of 58.05% [1] Financial Performance - The company recorded a loss attributable to shareholders of HKD 67.57 million, compared to a profit of HKD 113 million in the same period last year [1] - Earnings per share were reported at a loss of HKD 0.89 [1] Reasons for Decline - The decline in profit is primarily attributed to substantial fluctuations in the international trade contract prices of natural uranium, coupled with the impact of inventory accounting using the weighted average cost method, leading to unit sales costs exceeding the unit sales prices during the period [1] - Additionally, the drop in natural uranium prices adversely affected the performance of an associated company and a joint venture, resulting in decreased contributions compared to the same period in 2024 [1]

Core Viewpoint - Hengwei Group Holdings (08219) reported a mid-year performance for 2025, showing a revenue of approximately HKD 54.06 million, which represents an increase of about 4.34% compared to the same period in 2024 [1] Financial Performance - The company recorded a profit attributable to shareholders of approximately HKD 1.06 million, marking a turnaround from a loss in the previous year [1] - Basic earnings per share were approximately HKD 0.43 cents [1]

Core Viewpoint - Hengwei Group Holdings (08219) reported a mid-year performance for 2025, showing a revenue of approximately HKD 54.06 million, which represents an increase of about 4.34% compared to the same period in 2024 [1] Financial Performance - The profit attributable to the company's owners was approximately HKD 1.06 million, marking a turnaround from a loss to a profit year-on-year [1] - Basic earnings per share were approximately HKD 0.43 cents [1]

Group 1 - The company Zhejiang Shibao (01057) reported a mid-year performance for 2025, with operating revenue of approximately 1.524 billion yuan, representing a year-on-year increase of 35.32% [1] - The net profit attributable to shareholders of the listed company was approximately 93.0344 million yuan, reflecting a year-on-year growth of 39.09% [1] - The basic earnings per share were reported at 0.1131 yuan [1]

Core Viewpoint - 中核国际 (02302) reported a significant increase in revenue and a turnaround in profit for the six months ending June 30, 2025, primarily driven by a surge in uranium trading activities [1] Financial Performance - Revenue reached HKD 592 million, representing a year-on-year increase of 9151.72% [1] - Shareholders' profit amounted to HKD 10.359 million, compared to a loss of HKD 7.731 million in the same period last year, indicating a successful turnaround [1] - Basic earnings per share were HKD 0.0212 [1] Business Operations - The substantial revenue growth was mainly attributed to a significant increase in the trading volume of uranium, with approximately HKD 582 million of revenue generated from transactions involving natural uranium sold to independent third parties [1]

Core Viewpoint - Hengxin Technology (01085) reported a decline in revenue and a significant loss for the first half of 2025, primarily due to decreased income from its wireless communication segment [1] Financial Performance - The company achieved revenue of RMB 1.022 billion for the six months ending June 30, 2025, representing a year-on-year decrease of 8.35% [1] - The loss attributable to equity shareholders was RMB 70.42 million, compared to a profit of RMB 26.589 million in the same period last year [1] - Basic loss per share was RMB 0.152 [1] Segment Performance - Revenue from the wireless communication segment was approximately RMB 854 million in the first half of 2025, down about RMB 115 million or 11.9% from approximately RMB 969 million in the first half of 2024 [1]

Core Insights - The company reported a revenue of approximately 669 million, representing a year-on-year decrease of 21.3% [1] - Gross profit was about 105 million, down 50.3% year-on-year [1] - Net profit was 60.93 million, marking a turnaround from a loss to profit [1] - Earnings per share stood at 0.08 [1] Revenue and Profit Analysis - The decline in revenue is primarily attributed to intensified competition leading to a decrease in project unit prices [1] - The increase in net profit is mainly due to changes in the fair value of biological assets [1] - The company recognized a gain of 95 million from the fair value changes of biological assets during the period [1] Biological Assets Performance - For the six months ending June 30, 2025, the gains from biological assets were driven by natural growth [1] - In contrast, for the six months ending June 30, 2024, the company reported a loss of 254.4 million, primarily due to a decrease in the unit fair value of biological assets, consistent with the decline in market prices of experimental models [1]